The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PAβN) Permeabilizes the Outer Membrane of Gram-Negative Bacteria
Open accessAbstract
Active efflux of antimicrobial agents is a primary mechanism by which bacterial pathogens can become multidrug resistant. The combined use of efflux pump inhibitors (EPIs) with pump substrates is under exploration to overcome efflux-mediated multidrug resistance. Phenylalanine-arginine β-naphthylamide (PAβN) is a well-studied EPI that is routinely combined with fluoroquinolone antibiotics, but few studies have assessed its utility in combination with β-lactam antibiotics. The initial goal of this study was to assess the efficacy of β-lactams in combination with PAβN against the opportunistic pathogen, Pseudomonas aeruginosa. PAβN reduced the minimal inhibitory concentrations (MICs) of several β-lactam antibiotics against P. aeruginosa; however, the susceptibility changes were not due entirely to efflux inhibition. Upon PAβN treatment, intracellular levels of the chromosomally-encoded AmpC β-lactamase that inactivates β-lactam antibiotics were significantly reduced and AmpC levels in supernatants correspondingly increased, potentially due to permeabilization of the outer membrane. PAβN treatment caused a significant increase in uptake of 8-anilino-1-naphthylenesulfonic acid, a fluorescent hydrophobic probe, and sensitized P. aeruginosa to bulky antibiotics (e.g. vancomycin) that are normally incapable of crossing the outer membrane, as well as to detergent-like bile salts. Supplementation of growth media with magnesium to stabilize the outer membrane increased MICs in the presence of PAβN and restored resistance to vancomycin. Thus, PAβN permeabilizes bacterial membranes in a concentration-dependent manner at levels below those typically used in combination studies, and this additional mode of action should be considered when using PAβN as a control for efflux studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“incapable of crossing the outer membrane [27].”
Hoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J., & Schweizer, H. P. (1998) · Gene · doi:10.1016/s0378-1119(98)00130-9 · Cited by 1,922
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“aeruginosa are MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM, and differ in their expression patterns and substrate specificities [10].”
BackgroundEfflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 853
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa
Li, X. Z., Nikaido, H., & Poole, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1948 · Cited by 643
Loh, B., Grant, C., & Hancock, R. E. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.546 · Cited by 481
Active efflux of bile salts by Escherichia coli
Thanassi, D. G., Cheng, L. W., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2512-2518.1997 · Cited by 471
Lomovskaya, O., & Bostian, K. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.008 · Cited by 460
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 456
Jacobs, C., Huang, L. J., Bartowsky, E., Normark, S., & Park, J. T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06792.x · Cited by 400
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Moya, B., Dötsch, A., Juan, C., Blázquez, J., Zamorano, L., Haussler, S., & Oliver, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 287
Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy
Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W. V., & Pagès, J.-M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl493 · Cited by 270
Renau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
Yu, E. W., Aires, J. R., McDermott, G., & Nikaido, H. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6804-6815.2005 · Cited by 242
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J.-M., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 238
Li, X.-Z., Zhang, L., & Poole, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.433 · Cited by 176
Inhibitors of Multidrug Resistant Efflux Systems in Bacteria
Zechini, B., & Versace, I. (2009) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489109787236256 · Cited by 172
Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
Lomovskaya, O., & Watkins, W. (2001) · PubMed · Cited by 161
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
Askoura, M., Mattawa, W., Abujamel, T. S., & Taher, I. (2011) · Libyan Journal of Medicine · doi:10.3402/ljm.v6i0.5870 · Cited by 127
Mutation of nfxB Causes Global Changes in the Physiology and Metabolism of Pseudomonas aeruginosa
Stickland, H. G., Davenport, P. W., Lilley, K. S., Griffin, J. L., & Welch, M. (2010) · Journal of Proteome Research · doi:10.1021/pr9011415 · Cited by 104
Novel Antibiotics Targeting Respiratory ATP Synthesis in Gram-Positive Pathogenic Bacteria
Balemans, W., Vranckx, L., Lounis, N., Pop, O. I., Guillemont, J., Vergauwen, K., Mol, S., Gilissen, R., Motte, M., Lançois, D., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00273-12 · Cited by 103
Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
Matsumoto, Y., Hayama, K., Sakakihara, S., Nishino, K., Noji, H., Iino, R., & Yamaguchi, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018547 · Cited by 101
Nikaido, H. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80023-x · Cited by 98
Understanding efflux in Gram-negative bacteria: opportunities for drug discovery
Schweizer, H. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.688949 · Cited by 84
Bile Salts Induce Resistance to Polymyxin in Enterohemorrhagic Escherichia coliO157:H7
Kus, J. V., Gebremedhin, A., Dang, V., Tran, S., Serbanescu, A., & Foster, D. B. (2011) · Journal of Bacteriology · doi:10.1128/jb.00200-11 · Cited by 82
Providing β-Lactams a Helping Hand: Targeting the Ampc β-Lactamase Induction Pathway
Mark, B. L., Vocadlo, D. J., & Oliver, A. (2011) · Future Microbiology · doi:10.2217/fmb.11.128 · Cited by 68
Nicola, G., Tomberg, J., Pratt, R. F., Nicholas, R. A., & Davies, C. (2010) · Biochemistry · doi:10.1021/bi100879m · Cited by 60
Probing the Transmembrane Potential of Bacterial Cells by Voltage-Sensitive Dyes
Suzuki, H. R., Wang, Z., Yamakoshi, M., Kobayashi, M., & Nozawa, T. (2003) · Analytical Sciences · doi:10.2116/analsci.19.1239 · Cited by 46
Beadle, B. M., Nicholas, R. A., & Shoichet, B. K. (2001) · Protein Science · doi:10.1110/ps.52001 · Cited by 28
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Role of bacterial efflux pumps in biofilm formation
Alav, I., Sutton, J. M., & Rahman, K. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky042 · Cited by 504
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Metadata
- Authors
- Lamers, R. P., Cavallari, J. F., & Burrows, L. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-03-27
- Volume
- 8
- Issue
- 3
- Pages
- e60666
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2034401300
- Cited by
- 291
- References
- 36
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.